Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: Influence of arterial hypertension

Physiological Research

Volumn 57, Issue 1, 2008, Pages 13-22

  Prázný, Martin ^a   Jezkova J ^a   Horova E ^a   Lazarova V ^a   Hana V ^a   Kvasnicka J ^a   Pecen, L ^b   Marek, J ^a   Skrha J ^a   Krsek M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Cushing's syndrome; Endothelial function; Laser Doppler flowmetry; Oxidative stress; Vascular reactivity

Indexed keywords

BIOLOGICAL MARKER; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD CLOTTING; BODY MASS; CASE CONTROL STUDY; CUSHING SYNDROME; FEMALE; FIBRINOLYSIS; HUMAN; HYPEREMIA; HYPERTENSION; INSULIN RESISTANCE; LASER DOPPLER FLOWMETRY; MALE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; NONPARAMETRIC TEST; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; STATISTICAL ANALYSIS; VASCULAR ENDOTHELIUM;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD COAGULATION; BODY MASS INDEX; CASE-CONTROL STUDIES; CUSHING SYNDROME; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; HYDROCORTISONE; HYPEREMIA; HYPERTENSION; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; LASER-DOPPLER FLOWMETRY; MALE; MATCHED-PAIR ANALYSIS; MICROCIRCULATION; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 35348863063     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ALMAWI WY, MELEMEDJIAN OK: Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J Mol Endocrinol 28: 69-78, 2002.
2. AOKI M, NATA T, MORISHITA R, MATSUSHITA H, NAKAGAMI H, YAMAMOTO K, YAMAZAKI K, NAKABAYASHI M, OGIHARA T, KANEDA Y: Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38: 48-55, 2001.
3. BINGGELI C, SPIEKER LE, CORTI R, SUDANO I, STOJANOVIC V, HAYOZ D, LUSCHER TF, NOLL G: Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 42: 71-77, 2003.
4. BOSCARO M, SONINO N, SCARDA A, BARZON L, FALLO F, SARTORI MT, PATRASSI GM, GIROLAMI A: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87: 3662-3666, 2002.
5. CERIELLO A, FALLETI E, BORTOLOTTI N, MOTZ E, CAVARAPE A, RUSSO A, GONANO F, BARTOLI E: Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism Clin Exp 45: 498-501, 1996.
6. COLAO A, PIVONELLO R, SPIEZIA S, FAGGIANO A, FERONE D, FILIPPELLA M, MARZULLO P, CERBONE G, SICILIANI M, LOMBARDI G: Persistence of increased cardiovascular risk in patients with cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84: 2664-2672, 1999.
7. COMINACINI L, FRATTA PASINI A, GARBIN U, CAMPAGNOLA M, DAVOLI A, RIGONI A, ZENTI MG, PASTORINO AM, LO CASCIO V: E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 40: 584-589, 1997.
8. ETXABE J, VAZQUEZ J: Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40: 479-484, 1994.
9. FAGGIANO A, PIVONELLO R, SPIEZIA S, DE MARTINO MC, FILIPPELLA M, DI SOMMA C, LOMBARDI G, COLAO A: Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88: 2527-2533, 2003.
10. FRIEDMAN T, MASTORAKOS G, NEWMAN T, MULLEN N, HORTON E, COSTELLO R, PAPADOPOULOS N, CHROUSOS G: Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J 43: 645-655, 1996.
11. HARRISON D, GRIENDLING KK, LANDMESSER U, HORNIG B, DREXLER H: Role of oxidative stress in atherosclerosis. Am J Cardiol 91 (3A): 7A-11A, 2003.
12. JACOBY R, OWINGS J, ORTEGA T, GOSSELIN R, FELDMAN E: Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch Surg 136: 1003-1007, 2001.
13. KHAN F, ELHADD TA, GREENE SA, BELCH JJF: Impaired skin microvascular function in children, adolescents, and young adults with type I diabetes. Diabetes Care 23: 215-220, 2000.
14. KRŠEK M, ROSICKÁ M, NEDVÍDKOVÁ J, KVASNIČKOVÁ H, HÁNA V, MAREK J, HALUZÍK M, LAI EW, PACÁK K: Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: an in-vivo microdialysis study. Physiol Res 55: 421-428, 2006.
15. LANDMESSER U, HARRISON DG: Oxidative stress and vascular damage in hypertension. Coron Artery Dis 12: 455-461, 2001.
16. MANCINI T, KOLA B, MANTERO F, BOSCARO M, ARNALDI G: High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 61: 768-777, 2004.
17. MARUMO T, SCHINI-KERTH VB, BRANDES RP, BUSSE R: Glucocorticoids inhibit superoxide anion production and p22 Phox mRNA expression in human aortic smooth muscle cells. Hypertension 32: 1083-1088, 1998.
18. MATTHEWS D, HOSKER J, RUDENSKI A, NAYLOR B, TREACHER D, TURNER R: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
19. MCCORD J, FRIDOVICH I: Superoxide dismutase. J Biol Chem 244: 6049-6055, 1969.
20. PETROFSKY J, LEE S: The effects of type 2 diabetes and aging on vascular endothelial and autonomic function. Med Sci Monit 11: CR247-254, 2005.
21. RUMLEY AG, WOODWARD M, RUMLEY A, RUMLEY J, LOWE GDO: Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease. QJM 97: 809-816, 2004.
22. SACERDOTE A, WEISS K, TRAN T, NOOR BR, MCFARLANE SI: Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management. Curr Hypertens Rep 7: 212-218, 2005.
23. SCHALKWIJK CG, STEHOUWER CDA: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109: 143-159, 2005.
24. ŠKRHA J: Pathogenesis of angiopathy in diabetes. Acta Diabetol 40 (Suppl 2): S324-S329, 2003.
25. ŠKRHA J, HILGERTOVÁ J: Relationship of serum N-acetyl-beta-glucosaminidase activity to oxidative stress in diabetes mellitus. Clin Chim Acta 282: 167-174, 1999.
26. ŠKRHA J, PERUŠIČOVÁ J, ŠTOLBA P, STIBOR V, PÁV J: Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Clin Chim Acta 166: 135-141, 1987.
27. ŠKRHA J, PRÁZNÝ M, HAAS T, KVASNIČKA J, KALVODOVÁ B: Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients. J Diabetes Complications 15: 234-240, 2001.
28. ŠTULC T, KASALOVÁ Z, PRÁZNÝ M, VRABLÍK M, ŠKRHA J, ČEŠKA R: Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment. Physiol Res 52: 439-445, 2003.
29. VINCENT HK, TAYLOR AG: Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 30: 400-418, 2005.
30. WITH N, MATHIESEN EB, AMIRAL J, VISSAC AM, HANSEN JB: Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques. Thromb Haemost 96: 53-59, 2006.
31. YAGI H: A simple fluorimetric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216, 1976.
32. YVONNE-TEE GB, GHULAM RASOOL AH, HALIM AS, BDUL RAHMAN AR: Noninvasive assessment of cutaneous vascular function in vivo using capillaroscopy, plethysmography and laser-Doppler instruments: its strengths and weaknesses. Clin Hemorheol Microcirc 34: 457-473, 2006.